Sinovac to Move Listing to NASDAQ Global Exchange

Sinovac Biotech Ltd. will move the home for its stock listing from the NYSE Amex to the NASDAQ Global Market. The reason given for the change was “greater liquidity.” Target day for the transfer is November 16. Although most NASDAQ companies use a four-letter symbol, Sinovac will be allowed to keep its current three-letter identifier, SVA, so the new listing will have no effect on most investors. More details... Stock Symbol: (NYSE Amex: SVA)